Fruquintinib, Catalog: B1979

IN STOCK!
US$0.00

(Z)-6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carbimidic acid; HMPL-013

PRODUCT SUMMARY

Alternate Names (Z)-6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carbimidic acid; HMPL-013

Appearance Crystalline solid

CAS # 1194506-26-7

Molecular Formula C₂₁H₁₉N₃O₅

Molecular Weight 393.39

Purity ≥ 98% by HPLC

Solubility DMSO (>6 mg/ml)

SMILES CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC

InChi InChI=1S/C21H19N3O5/c1-11-19(20(25)22-2)13-6-5-12(7-16(13)28-11)29-21-14-8-17(26-3)18(27-4)9-15(14)23-10-24-21/h5-10H,1-4H3,(H,22,25)

InChi Key BALLNEJQLSTPIO-UHFFFAOYSA-N

PubChem CID 44480399

Handling Protect from air and light

Storage Conditions -20°C

Shipping Conditions Gel Pack

Usage For Research Use Only! Not For Use in Humans.

Handling Do not take it internally. Wear a glove and mask when handling the product. Protect from air and moisture.

DESCRIPTION

Fruquintinib (HMPL-013) is a potent and selective vascular endothelial growth factor receptors1/2/3 (VEGFR 1/2/3) inhibitor with IC₅₀s of 33, 0.35, and 35 nM, respectively. It only weakly inhibits RET, FGFR-1 and c-kit kinases.